French pharmaceutical major Sanofi SA (SNY) said on Thursday that it would acquire U.S.-based Vigil Neuroscience, Inc. (VIGL) for about $470 million. Vigil is a clinical-stage biotechnology company …
Vigil Neuroscience Stock Triples Pre-market On Acquisition By Sanofi: Retail Goes Super Bullish
view original post